{"pmid":32426754,"pmcid":"PMC7188422","title":"The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.","text":["The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.","The coronavirus disease 2019 pandemic has disproportionally strained intensive care services worldwide. Large areas of uncertainly regarding epidemiology, physiology, practice patterns, and resource demands for patients with coronavirus disease 2019 require rapid collection and dissemination of data. We describe the conception and implementation of an intensive care database rapidly developed and designed to meet data analytic needs in response to the coronavirus disease 2019 pandemic-the multicenter, international Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study. Design: Prospective cohort study and disease registry. Setting: Multinational cohort of ICUs. Patients: Critically ill patients with a diagnosis of coronavirus disease 2019. Interventions: None. Measurements and Main Results: Within 2 weeks of conception of the Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study, study leadership was convened, registry case report forms were designed, electronic data entry set up, and more than 250 centers had submitted the protocol for institutional review board approval, with more than 100 cases entered. Conclusions: The Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study provides an example of a rapidly deployed, international, pandemic registry that seeks to provide near real-time analytics and information regarding intensive care treatments and outcomes for patients with coronavirus disease 2019.","Crit Care Explor","Walkey, Allan J","Kumar, Vishakha K","Harhay, Michael O","Bolesta, Scott","Bansal, Vikas","Gajic, Ognjen","Kashyap, Rahul","32426754"],"abstract":["The coronavirus disease 2019 pandemic has disproportionally strained intensive care services worldwide. Large areas of uncertainly regarding epidemiology, physiology, practice patterns, and resource demands for patients with coronavirus disease 2019 require rapid collection and dissemination of data. We describe the conception and implementation of an intensive care database rapidly developed and designed to meet data analytic needs in response to the coronavirus disease 2019 pandemic-the multicenter, international Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study. Design: Prospective cohort study and disease registry. Setting: Multinational cohort of ICUs. Patients: Critically ill patients with a diagnosis of coronavirus disease 2019. Interventions: None. Measurements and Main Results: Within 2 weeks of conception of the Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study, study leadership was convened, registry case report forms were designed, electronic data entry set up, and more than 250 centers had submitted the protocol for institutional review board approval, with more than 100 cases entered. Conclusions: The Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study provides an example of a rapidly deployed, international, pandemic registry that seeks to provide near real-time analytics and information regarding intensive care treatments and outcomes for patients with coronavirus disease 2019."],"journal":"Crit Care Explor","authors":["Walkey, Allan J","Kumar, Vishakha K","Harhay, Michael O","Bolesta, Scott","Bansal, Vikas","Gajic, Ognjen","Kashyap, Rahul"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426754","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/CCE.0000000000000113","keywords":["coronavirus disease 2019","registry"],"topics":["Treatment"],"weight":1,"_version_":1667252837888819202,"score":9.490897,"similar":[{"pmid":32452888,"title":"ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.","text":["ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.","OBJECTIVES: To determine mortality rates among adults with critical illness from coronavirus disease 2019. DESIGN: Observational cohort study of patients admitted from March 6, 2020, to April 17, 2020. SETTING: Six coronavirus disease 2019 designated ICUs at three hospitals within an academic health center network in Atlanta, Georgia, United States. PATIENTS: Adults greater than or equal to 18 years old with confirmed severe acute respiratory syndrome-CoV-2 disease who were admitted to an ICU during the study period. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 217 critically ill patients, mortality for those who required mechanical ventilation was 35.7% (59/165), with 4.8% of patients (8/165) still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/217) patients have survived to hospital discharge. Mortality was significantly associated with older age, lower body mass index, chronic renal disease, higher Sequential Organ Failure Assessment score, lower PaO2/FIO2 ratio, higher D-dimer, higher C-reactive protein, and receipt of mechanical ventilation, vasopressors, renal replacement therapy, or vasodilator therapy. CONCLUSIONS: Despite multiple reports of mortality rates exceeding 50% among critically ill adults with coronavirus disease 2019, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness.","Crit Care Med","Auld, Sara C","Caridi-Scheible, Mark","Blum, James M","Robichaux, Chad","Kraft, Colleen","Jacob, Jesse T","Jabaley, Craig S","Carpenter, David","Kaplow, Roberta","Hernandez-Romieu, Alfonso C","Adelman, Max W","Martin, Greg S","Coopersmith, Craig M","Murphy, David J","32452888"],"abstract":["OBJECTIVES: To determine mortality rates among adults with critical illness from coronavirus disease 2019. DESIGN: Observational cohort study of patients admitted from March 6, 2020, to April 17, 2020. SETTING: Six coronavirus disease 2019 designated ICUs at three hospitals within an academic health center network in Atlanta, Georgia, United States. PATIENTS: Adults greater than or equal to 18 years old with confirmed severe acute respiratory syndrome-CoV-2 disease who were admitted to an ICU during the study period. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 217 critically ill patients, mortality for those who required mechanical ventilation was 35.7% (59/165), with 4.8% of patients (8/165) still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/217) patients have survived to hospital discharge. Mortality was significantly associated with older age, lower body mass index, chronic renal disease, higher Sequential Organ Failure Assessment score, lower PaO2/FIO2 ratio, higher D-dimer, higher C-reactive protein, and receipt of mechanical ventilation, vasopressors, renal replacement therapy, or vasodilator therapy. CONCLUSIONS: Despite multiple reports of mortality rates exceeding 50% among critically ill adults with coronavirus disease 2019, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness."],"journal":"Crit Care Med","authors":["Auld, Sara C","Caridi-Scheible, Mark","Blum, James M","Robichaux, Chad","Kraft, Colleen","Jacob, Jesse T","Jabaley, Craig S","Carpenter, David","Kaplow, Roberta","Hernandez-Romieu, Alfonso C","Adelman, Max W","Martin, Greg S","Coopersmith, Craig M","Murphy, David J"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452888","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/CCM.0000000000004457","locations":["Atlanta","Georgia","United States"],"countries":["Georgia","United States"],"countries_codes":["GEO|Georgia","USA|United States"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798545178624,"score":172.0009},{"pmid":32248675,"title":"Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","text":["Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness.","Crit Care Resusc","Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D","32248675"],"abstract":["Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness."],"journal":"Crit Care Resusc","authors":["Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32248675","source":"PubMed","week":"202015|Apr 06 - Apr 12","locations":["China","China","China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Nitric Oxide"],"topics":["Case Report"],"weight":1,"_version_":1666138491006746624,"score":159.37094},{"pmid":32440887,"title":"The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.","text":["The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.","The outbreak of SARS-CoV-2 is the worst healthcare emergency of this century, and its impact on pediatrics and neonatology is still largely unknown. The European Society for Pediatric and Neonatal Intensive Care (ESPNIC) launched the EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) international, multicenter, and multidisciplinary initiative to study the epidemiology, clinical course, and outcomes of pediatric and neonatal SARS-CoV-2 infections. EPICENTRE background and aims are presented together with protocol details. EPICENTRE is open to centers all over the world, and this will allow to provide a pragmatic picture of the epidemic, with a particular attention to pediatric and neonatal critical care issues.Conclusions: EPICENTRE will allow researchers to clarify the epidemiology, clinical presentation, and outcomes of pediatric and neonatal SARS-CoV-2 infection, refining its clinical management and hopefully providing new insights for clinicians.What is Known:* COVID19 is the new disease caused by SARS-CoV-2 infection and is spreading around the globe.* Majority of data available about SARS-CoV-2 infections originates from adult patients.What is New:* EPICENTRE is the first international, multicenter, multidisciplinary, meta-data driven, hospital-based, online, prospective cohort registry dedicated to neonatal and pediatric SARS-CoV-2 infections.* EPICENTRE will allow to understand epidemiology and physiopathology of COVID19.","Eur J Pediatr","De Luca, Daniele","Rava, Lucilla","Nadel, Simon","Tissieres, Pierre","Gawronski, Orsola","Perkins, Elisabeth","Chidini, Giovanna","Tingay, David G","32440887"],"abstract":["The outbreak of SARS-CoV-2 is the worst healthcare emergency of this century, and its impact on pediatrics and neonatology is still largely unknown. The European Society for Pediatric and Neonatal Intensive Care (ESPNIC) launched the EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) international, multicenter, and multidisciplinary initiative to study the epidemiology, clinical course, and outcomes of pediatric and neonatal SARS-CoV-2 infections. EPICENTRE background and aims are presented together with protocol details. EPICENTRE is open to centers all over the world, and this will allow to provide a pragmatic picture of the epidemic, with a particular attention to pediatric and neonatal critical care issues.Conclusions: EPICENTRE will allow researchers to clarify the epidemiology, clinical presentation, and outcomes of pediatric and neonatal SARS-CoV-2 infection, refining its clinical management and hopefully providing new insights for clinicians.What is Known:* COVID19 is the new disease caused by SARS-CoV-2 infection and is spreading around the globe.* Majority of data available about SARS-CoV-2 infections originates from adult patients.What is New:* EPICENTRE is the first international, multicenter, multidisciplinary, meta-data driven, hospital-based, online, prospective cohort registry dedicated to neonatal and pediatric SARS-CoV-2 infections.* EPICENTRE will allow to understand epidemiology and physiopathology of COVID19."],"journal":"Eur J Pediatr","authors":["De Luca, Daniele","Rava, Lucilla","Nadel, Simon","Tissieres, Pierre","Gawronski, Orsola","Perkins, Elisabeth","Chidini, Giovanna","Tingay, David G"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440887","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00431-020-03690-9","keywords":["children","coronavirus","database","neonate","outbreak","pandemic"],"weight":0,"_version_":1667535119494152193,"score":158.19724},{"pmid":32420720,"title":"Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists.","text":["Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists.","OBJECTIVE: In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic, which causes coronavirus disease 2019, there is a recognized need to expand critical care services and beds beyond the traditional boundaries. There is considerable concern that widespread infection will result in a surge of critically ill patients that will overwhelm our present adult ICU capacity. In this setting, one proposal to add \"surge capacity\" has been the use of PICU beds and physicians to care for these critically ill adults. DESIGN: Narrative review/perspective. SETTING: Not applicable. PATIENTS: Not applicable. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The virus's high infectivity and prolonged asymptomatic shedding have resulted in an exponential growth in the number of cases in the United States within the past weeks with many (up to 6%) developing acute respiratory distress syndrome mandating critical care services. Coronavirus disease 2019 critical illness appears to be primarily occurring in adults. Although pediatric intensivists are well versed in the care of acute respiratory distress syndrome from viral pneumonia, the care of differing aged adult populations presents some unique challenges. In this statement, a team of adult and pediatric-trained critical care physicians provides guidance on common \"adult\" issues that may be encountered in the care of these patients and how they can best be managed in a PICU. CONCLUSIONS: This concise scientific statement includes references to the most recent and relevant guidelines and clinical trials that shape management decisions. The intention is to assist PICUs and intensivists in rapidly preparing for care of adult coronavirus disease 2019 patients should the need arise.","Pediatr Crit Care Med","Remy, Kenneth E","Verhoef, Philip A","Malone, Jay R","Ruppe, Michael D","Kaselitz, Timothy B","Lodeserto, Frank","Hirshberg, Eliotte L","Slonim, Anthony","Dezfulian, Cameron","32420720"],"abstract":["OBJECTIVE: In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic, which causes coronavirus disease 2019, there is a recognized need to expand critical care services and beds beyond the traditional boundaries. There is considerable concern that widespread infection will result in a surge of critically ill patients that will overwhelm our present adult ICU capacity. In this setting, one proposal to add \"surge capacity\" has been the use of PICU beds and physicians to care for these critically ill adults. DESIGN: Narrative review/perspective. SETTING: Not applicable. PATIENTS: Not applicable. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The virus's high infectivity and prolonged asymptomatic shedding have resulted in an exponential growth in the number of cases in the United States within the past weeks with many (up to 6%) developing acute respiratory distress syndrome mandating critical care services. Coronavirus disease 2019 critical illness appears to be primarily occurring in adults. Although pediatric intensivists are well versed in the care of acute respiratory distress syndrome from viral pneumonia, the care of differing aged adult populations presents some unique challenges. In this statement, a team of adult and pediatric-trained critical care physicians provides guidance on common \"adult\" issues that may be encountered in the care of these patients and how they can best be managed in a PICU. CONCLUSIONS: This concise scientific statement includes references to the most recent and relevant guidelines and clinical trials that shape management decisions. The intention is to assist PICUs and intensivists in rapidly preparing for care of adult coronavirus disease 2019 patients should the need arise."],"journal":"Pediatr Crit Care Med","authors":["Remy, Kenneth E","Verhoef, Philip A","Malone, Jay R","Ruppe, Michael D","Kaselitz, Timothy B","Lodeserto, Frank","Hirshberg, Eliotte L","Slonim, Anthony","Dezfulian, Cameron"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420720","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/PCC.0000000000002429","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"e_drugs":["Midazolam"],"topics":["Prevention"],"weight":1,"_version_":1667159284543127552,"score":155.1748},{"pmid":32434518,"title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.","text":["Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.","BACKGROUND: Patients with critical illness due to infection with the 2019 coronavirus disease (COVID-19) show rapid disease progression to acute respiratory failure. The study aimed to screen the most useful predictive factor for critical illness caused by COVID-19. METHODS: The study prospectively involved 61 patients with COVID-19 infection as a derivation cohort, and 54 patients as a validation cohort. The predictive factor for critical illness was selected using LASSO regression analysis. A nomogram based on non-specific laboratory indicators was built to predict the probability of critical illness. RESULTS: The neutrophil-to-lymphocyte ratio (NLR) was identified as an independent risk factor for critical illness in patients with COVID-19 infection. The NLR had an area under receiver operating characteristic of 0.849 (95% confidence interval [CI], 0.707 to 0.991) in the derivation cohort and 0.867 (95% CI 0.747 to 0.944) in the validation cohort, the calibration curves fitted well, and the decision and clinical impact curves showed that the NLR had high standardized net benefit. In addition, the incidence of critical illness was 9.1% (1/11) for patients aged >/= 50 and having an NLR < 3.13, and 50% (7/14) patients with age >/= 50 and NLR >/= 3.13 were predicted to develop critical illness. Based on the risk stratification of NLR according to age, this study has developed a COVID-19 pneumonia management process. CONCLUSIONS: We found that NLR is a predictive factor for early-stage prediction of patients infected with COVID-19 who are likely to develop critical illness. Patients aged >/= 50 and having an NLR >/= 3.13 are predicted to develop critical illness, and they should thus have rapid access to an intensive care unit if necessary.","J Transl Med","Liu, Jingyuan","Liu, Yao","Xiang, Pan","Pu, Lin","Xiong, Haofeng","Li, Chuansheng","Zhang, Ming","Tan, Jianbo","Xu, Yanli","Song, Rui","Song, Meihua","Wang, Lin","Zhang, Wei","Han, Bing","Yang, Li","Wang, Xiaojing","Zhou, Guiqin","Zhang, Ting","Li, Ben","Wang, Yanbin","Chen, Zhihai","Wang, Xianbo","32434518"],"abstract":["BACKGROUND: Patients with critical illness due to infection with the 2019 coronavirus disease (COVID-19) show rapid disease progression to acute respiratory failure. The study aimed to screen the most useful predictive factor for critical illness caused by COVID-19. METHODS: The study prospectively involved 61 patients with COVID-19 infection as a derivation cohort, and 54 patients as a validation cohort. The predictive factor for critical illness was selected using LASSO regression analysis. A nomogram based on non-specific laboratory indicators was built to predict the probability of critical illness. RESULTS: The neutrophil-to-lymphocyte ratio (NLR) was identified as an independent risk factor for critical illness in patients with COVID-19 infection. The NLR had an area under receiver operating characteristic of 0.849 (95% confidence interval [CI], 0.707 to 0.991) in the derivation cohort and 0.867 (95% CI 0.747 to 0.944) in the validation cohort, the calibration curves fitted well, and the decision and clinical impact curves showed that the NLR had high standardized net benefit. In addition, the incidence of critical illness was 9.1% (1/11) for patients aged >/= 50 and having an NLR < 3.13, and 50% (7/14) patients with age >/= 50 and NLR >/= 3.13 were predicted to develop critical illness. Based on the risk stratification of NLR according to age, this study has developed a COVID-19 pneumonia management process. CONCLUSIONS: We found that NLR is a predictive factor for early-stage prediction of patients infected with COVID-19 who are likely to develop critical illness. Patients aged >/= 50 and having an NLR >/= 3.13 are predicted to develop critical illness, and they should thus have rapid access to an intensive care unit if necessary."],"journal":"J Transl Med","authors":["Liu, Jingyuan","Liu, Yao","Xiang, Pan","Pu, Lin","Xiong, Haofeng","Li, Chuansheng","Zhang, Ming","Tan, Jianbo","Xu, Yanli","Song, Rui","Song, Meihua","Wang, Lin","Zhang, Wei","Han, Bing","Yang, Li","Wang, Xiaojing","Zhou, Guiqin","Zhang, Ting","Li, Ben","Wang, Yanbin","Chen, Zhihai","Wang, Xianbo"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434518","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s12967-020-02374-0","keywords":["2019-ncov","covid-19","model","nlr","prognosis","sars-cov"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667521393792647169,"score":147.36583}]}